Glazer Capital, LLC Verona Pharma PLC Transaction History
Glazer Capital, LLC
- $2.98 Billion
- Q3 2025
A detailed history of Glazer Capital, LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Glazer Capital, LLC holds 3,205,878 shares of VRNA stock, worth $343 Million. This represents 11.48% of its overall portfolio holdings.
Number of Shares
3,205,878Holding current value
$343 Million% of portfolio
11.48%Shares
1 transactions
Others Institutions Holding VRNA
# of Institutions
273Shares Held
76.9MCall Options Held
686KPut Options Held
442K-
Pentwater Capital Management LP Naples, FL5.3MShares$567 Million3.55% of portfolio
-
Hbk Investments L P Dallas, TX4.26MShares$456 Million6.29% of portfolio
-
Fil LTD Hamilton, D03.49MShares$373 Million0.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$362 Million15.27% of portfolio
-
Davidson Kempner Capital Management LP New York, NY3.27MShares$350 Million10.89% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $6.52B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...